Implanet S.A. (EPA:ALIMP)

France · Delayed Price · Currency is EUR

0.202

+0.002 (1.00%)

Apr 28, 2026, 4:00 PM CET

98.62% (1Y)

Market Cap	29.05M
Revenue (ttm)	12.47M
Net Income (ttm)	-4.38M
Shares Out	143.82M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,451
Average Volume	107,930
Open	0.200
Previous Close	0.200
Day's Range	0.200 - 0.205
52-Week Range	0.080 - 0.450
Beta	0.65
RSI	39.96
Earnings Date	Sep 15, 2026

About Implanet

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides an ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The co... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2006

Employees 46

Stock Exchange Euronext Paris

Ticker Symbol ALIMP

Full Company Profile

Financial Performance

In 2025, Implanet's revenue was 12.47 million, an increase of 32.62% compared to the previous year's 9.41 million. Losses were -4.38 million, 0.37% more than in 2024.

Financial Statements

News

There is no news available yet.